Legend Biotech director reports 16 ordinary shares

Legend Biotech Corp director Wang Ye reported ownership of 16 Ordinary Shares, held directly.

Accepted by SEC EDGAR 03/18/2026 - 06:48 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Legend Biotech Corp director Wang Ye reported ownership of 16 Ordinary Shares, held directly. The filing notes that the company’s Ordinary Shares may be represented by American Depositary Shares (ADSs), with each ADS representing two Ordinary Shares of Legend Biotech.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Wang Ye

Role Director

Type	Security	Shares	Price	Value
Holding	Ordinary Shares	--	--	--

Holdings: Ordinary Shares — 16 shares (Direct)

Footnotes (1)

1. F1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Legend Biotech (LEGN) shares does Wang Ye report owning?

Wang Ye reports owning 16 Ordinary Shares of Legend Biotech Corp. These shares are listed as held directly, reflecting Wang Ye’s personal ownership position as disclosed in the filing’s ownership table for Ordinary Shares.

Are Wang Ye’s Legend Biotech (LEGN) shares held directly or indirectly?

Wang Ye’s 16 Ordinary Shares of Legend Biotech are held directly. The ownership code is marked as direct, indicating the shares are not reported as being held through an intermediary entity or indirect ownership structure.

What is the ADS to Ordinary Share ratio for Legend Biotech (LEGN)?

Each American Depositary Share (ADS) of Legend Biotech represents two Ordinary Shares. The filing explains that the company’s Ordinary Shares may be represented by ADSs, and explicitly states that one ADS corresponds to two underlying Ordinary Shares.

Does the Wang Ye filing for Legend Biotech (LEGN) show any share purchases or sales?

The filing does not show any explicit purchases or sales by Wang Ye. It reports a holding entry for 16 Ordinary Shares, with no transaction code indicating a buy, sell, gift, or other type of share transfer activity.

What type of security does Wang Ye hold in Legend Biotech (LEGN)?

Wang Ye holds Ordinary Shares of Legend Biotech Corp. The filing’s transaction table identifies the security title as “Ordinary Shares,” and also notes that these may be represented by American Depositary Shares, each ADS equal to two Ordinary Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Ye

(Last) (First) (Middle)

C/O LEGEND BIOTECH CORP

2101 COTTONTAIL LANE

(Street)

SOMERSET NEW JERSEY 08873

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Legend Biotech Corp [ LEGN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)	16	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ James Pepin, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)